Pere Dalmases Barjoan

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 15 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Inke, S.a., Laboratorios Lesvi, S.l., Vita-Invest S.a.. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pere Dalmases Barjoan. Retrieved from https://idiyas.com/inventor/pere-dalmases-barjoan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 1)

% Patents Active = 60.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 12)

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

San Feliu De Llobregat, ES (2010)
Sant Feliu de Llobregat, ES (1994 - 2014)
Barcelona, ES (2010 - 2020)

Company Filing History:

Laboratorios Lesvi, S.l.

Laboratories Lesvi S.l.

patents

5. 1 out of 1

Vita Cientifica, S.a.

patent

Years Active: 1994-2020

Loading Chart...

Areas of Expertise:

Pharmaceutical Active Compounds

Synthesis Intermediates

Polymorphic Forms

Beta-2 Agonists

Dolasetron

Zolmitriptan

Rufinamide

Valsartan

Granisetron

Irbesartan

Olanzapine

Drug Synthesis

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10800748 - Process for the manufacture of R-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylaminoethyl]-2H-1,4-benzoxazin-3(4H)-one hydrochloride (2020-10-13),

2. 10131630 - Process for preparing (3RS)-3-[(2SR)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide (2018-11-20),

3. 9309186 - Polymorphic form of a long-acting beta-2 adrenoceptor agonist (2016-04-12),

4. 8884026 - Process for preparing rufinamide intermediate (2014-11-11),

5. 8653280 - Process for the preparation of asenapine (2014-02-18),

6. 8304426 - Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it (2012-11-06),

7. 8129522 - Method for preparing a mixed solvate of olanzapine (2012-03-06),

8. 7964749 - Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound (2011-06-21),

9. 7858821 - Intermediate compounds useful to prepare dolasetron (2010-12-28),

10. 7807827 - Procedure for preparing 11-(4-[2-(2-hydroxyethoxy)ethyl]-1-piperazineyl)-dibenzo[b,f] [1,4]thiazepine (2010-10-05),

11. 7759484 - Mixed solvate of olanzapine, method for preparing it and method for preparing form I of olanzapine therefrom (2010-07-20),

12. 7745628 - Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them (2010-06-29),

13. 7741492 - Method for obtaining a pharmaceutically active compound (Irbesartan) and its synthesis intermediate (2010-06-22),

14. 7728021 - Process for the preparation of Valsartan and precursors thereof (2010-06-01),

15. 7563904 - Synthesis intermediates useful for preparing zolmitriptan (2009-07-21),

Title: Pere Dalmases Barjoan: Innovator in Pharmaceutical Processes

Introduction

Pere Dalmases Barjoan, based in Sant Feliu de Llobregat, Spain, is a notable inventor with an impressive portfolio of 20 patents. His work primarily focuses on innovative processes in the pharmaceutical industry, aiming to enhance production efficiency and purity.

Latest Patents

Among his recent patents, one highlights a process for the manufacture of R-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylaminoethyl]-2H-1,4-benzoxazin-3(4H)-one hydrochloride. This invention presents an improved method for producing this compound with high purity and yield, utilizing specific salts to optimize the manufacturing process. Another recent patent details an efficient and environmentally friendly process for preparing (3RS)-3-[(2SR)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide, designed for industrial-scale applications while maintaining high yield and purity.

Career Highlights

Pere Dalmases has contributed significantly to the pharmaceutical sector, with experience at reputable companies such as Inke, S.A. and Laboratorios Lesvi, S.L. His professional journey reflects a dedication to innovation and high-quality production methods in the competitive world of pharmaceuticals.

Collaborations

Throughout his career, Pere has collaborated with skilled professionals, including Joan Huguet Clotet and Juan Huguet Clotet. These partnerships have been instrumental in fostering innovative approaches to pharmaceutical manufacturing.

Conclusion

Pere Dalmases Barjoan stands out as a prominent inventor dedicated to advancing pharmaceutical processes. His innovative patents and collaborations speak to his commitment to excellence and the betterment of the industry. Through his inventions, he continues to impact the field positively, paving the way for more efficient and environmentally friendly manufacturing practices.

Profile summary based on public USPTO records.